跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,484 条关于
“GHP-88310”
全部
2,484
临床试验
1,440
药物
407
机构
14
资讯
623
上个月
Oral Antiviral GHP-88310 Blocks Measles Transmission in Ferret Model, Paving Way for Clinical Trials
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
11个月前
Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market
9个月前
Lir Life Sciences Advances Needle-Free Obesity Treatment with Novel Transdermal GLP/GIP Delivery Platform
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
5个月前
BrightGene's Oral GLP-1/GIP Dual Agonist BGM0504 Shows Promising Weight Loss Results in Phase 1 Trials
去年
Hengrui and Kailera's Dual GLP-1/GIP Obesity Drug Achieves 18% Weight Loss in Phase 3 Trial
上个月
Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity
去年
Viking Therapeutics Advances Novel Oral GLP-1/GIP Dual Agonist VK2735 to Phase 2 Trial for Obesity Treatment
2个月前
GLP-1 Weight-Loss Boom Creates Tissue-Restoration Gap as Conexeu Advances Regenerative Platform Toward 2027 FDA Submission
第 1 页,共 63 页
上一页
下一页